Evidence map›Paper›PMID 33143154›Full record

ArticleMaterials (Basel, Switzerland)2020

Optimizing Laser Powder Bed Fusion Parameters for IN-738LC by Response Surface Method.

Mireia Vilanova, Rubén Escribano-García, Teresa Guraya, Maria San Sebastian

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mireia VilanovaLORTEK Technological Centre, Basque Research and Technology Alliance (BRTA), Arranomendia Kalea 4A, 20240 Ordizia, Spain.
Rubén Escribano-GarcíaLORTEK Technological Centre, Basque Research and Technology Alliance (BRTA), Arranomendia Kalea 4A, 20240 Ordizia, Spain.
Teresa GurayaDepartment of Mining and Metallurgical Engineering and Materials Science, University of the Basque Country UPV/EHU, Rafael Moreno "Pitxitxi", 2, 48013 Bilbao, Spain.ORCID 0000-0002-5025-8304
Maria San SebastianLORTEK Technological Centre, Basque Research and Technology Alliance (BRTA), Arranomendia Kalea 4A, 20240 Ordizia, Spain.ORCID 0000-0003-4056-0099

Funding

Elkartek Programme KK-2018/00115
6 · The paper itself

Abstract

A method to find the optimum process parameters for manufacturing nickel-based superalloy Inconel 738LC by laser powder bed fusion (LPBF) technology is presented. This material is known to form cracks during its processing by LPBF technology; thus, process parameters have to be optimized to get a high quality product. In this work, the objective of the optimization was to obtain samples with fewer pores and cracks. A design of experiments (DoE) technique was implemented to define the reduced set of samples. Each sample was manufactured by LPBF with a specific combination of laser power, laser scan speed, hatch distance and scan strategy parameters. Using the porosity and crack density results obtained from the DoE samples, quadratic models were fitted, which allowed identifying the optimal working point by applying the response surface method (RSM). Finally, five samples with the predicted optimal processing parameters were fabricated. The examination of these samples showed that it was possible to manufacture IN738LC samples free of cracks and with a porosity percentage below 0.1%. Therefore, it was demonstrated that RSM is suitable for obtaining optimum process parameters for IN738LC alloy manufacturing by LPBF technology.

Indexed as

crackingInconel 738LClaser powder bed fusion (LPBF)process parameter optimizationresponse surface method (RSM)

Identifiers

PMID33143154
PMCPMC7663315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.